ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Market Cap
TRY2.66bn
Enterprise Value
TRY2.32bn
Revenue
TRY238.21m

Annual income statement for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	Interim Report	ARS	ARS	ARS
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	20.8	422	410	468	238
Cost of Revenue
Gross Profit	15.2	373	359	402	190
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	12.1	71.3	70.3	31	160
Operating Profit	8.78	350	340	437	78.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6.92	360	462	45.8	-146
Provision for Income Taxes
Net Income After Taxes	6.44	316	443	-10.1	-137
Minority Interest
Net Income Before Extraordinary Items
Net Income	6.99	293	433	-21.1	-137
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	6.99	293	433	-21.1	-137
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.064	2.67	2.86	-0.191	-0.598
Dividends per Share